サンプル依頼リスト カート
  • English
  • Korean
表紙：臨床検査薬の世界市場規模調査＆予測、タイプ別、エンドユーザー別、地域別分析、2022-2029年
市場調査レポート
商品コード
1258073

臨床検査薬の世界市場規模調査＆予測、タイプ別、エンドユーザー別、地域別分析、2022-2029年

Global Clinical Laboratory Tests Market Size study & Forecast, by Type, By End-Use, and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
臨床検査薬の世界市場規模調査＆予測、タイプ別、エンドユーザー別、地域別分析、2022-2029年
出版日: 2023年04月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床検査薬の世界市場は、2021年に約947億米ドルと評価され、予測期間2022-2029年には9.4%以上の成長率で堅調に成長すると予測されています。

臨床検査は、幅広い健康状態や疾患を診断またはモニタリングするために、血液、尿、その他の体液、または組織のサンプルに対して行われる医療検査です。これらの検査は、感染症、がん、遺伝性疾患などの特定の疾患だけでなく、人の健康全般に関する情報を提供することができます。市場の需要は主に、世界人口の高齢化に伴い、高齢者が診断検査を必要とする加齢に関連した病気や症状を発症しやすくなること、世界中の政府がヘルスケアインフラに投資し、国民のヘルスケアアクセスを促進していることなどの要因によって、臨床検査薬に対する需要が増加すると予想されています。その結果、より多くの人々がヘルスケアサービスを利用できるようになり、臨床検査薬が必要な病気と診断されるようになったため、臨床検査薬に対する需要が増加しています。

さらに、糖尿病、心血管疾患、がんなどの慢性疾患の世界の負担が増加しており、これらの疾患の診断、モニタリング、管理のための臨床検査薬に対する需要が、市場成長の主要な促進要因となっています。世界保健機関（WHO）によると、非伝染性疾患（NCDs）は年間4,100万人の死亡者数を占め、これは全世界の死亡者数の71%にあたります。30歳から69歳までの間に、年間1,500万人以上の人々がNCDによって亡くなっており、これらの「早すぎる」死亡の85％は低・中所得国で起こっています。NCDによる死亡の大部分（年間1,790万人）は、心血管疾患によるもので、次いで悪性腫瘍（930万人）、呼吸器疾患（410万人）、糖尿病（150万人）となっています。早死にするNCD関連死亡のほぼ8割がこの4つの疾患によるものであり、これらの要因が世界市場における臨床検査薬の需要を拡大すると予想されます。さらに、効率的な業務をサポートするデータ管理・情報化ソリューションの採用・開拓や、最近の技術の進歩は、今後数年間の市場成長にとって有利な機会をもたらしています。しかし、曖昧な規制の枠組みが、2022-2029年の予測期間における市場の成長を制限しています。

臨床検査薬の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他の地域です。北米は、地域的なバイオテクノロジー事業と同様に、いくつかの医薬品の広範な使用により、収益の面で市場を独占しています。また、高齢者人口の増加に伴い、診断ツールの需要も増加しており、技術革新の進展がこの地域の市場を牽引していると考えられます。一方、アジア太平洋地域は、予測期間中、最も高い成長率で成長すると予想されています。研究開発部門やヘルスケア部門への投資の増加などの要因が、予測期間中の市場成長を急拡大させています。

本調査の目的は、近年における様々なセグメントや国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界およびセグメント別市場の推定・予測、2019年～2029年
    • 臨床検査薬市場、地域別、2019-2029年
    • 臨床検査薬市場、タイプ別、2019-2029年
    • 臨床検査薬市場、エンドユーザー別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 臨床検査薬の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 臨床検査薬の世界市場力学

  • 臨床検査薬市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 老年人口の増加
      • ヘルスケア推進に向けた政府の取り組み
      • 慢性疾患や感染症の増加
    • 市場の課題
      • 曖昧な規制の枠組み
    • 市場機会
      • データ管理および情報学ソリューションの開発
      • 最近の技術の進歩

第4章 臨床検査薬の世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 主な投資機会
  • 主要成功戦略
  • 業界関係者見通し
  • アナリストの提言と結論

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 臨床検査薬の世界市場：タイプ別

  • マーケットスナップショット
  • 臨床検査薬の世界市場：タイプ別、性能別- ポテンシャル分析
  • 臨床検査薬の世界市場：タイプ別推定・予測2019-2029
  • 臨床検査薬市場、サブセグメント別分析
    • 完全血球計算
    • HGB/HCT検査
    • メタボリックパネルの基本検査
    • BUNクレアチニン検査
    • 電解質検査
    • HbA1c検査
    • メタボリックパネルの総合的な検査
    • 肝臓パネル検査
    • 腎臓パネル検査
    • 脂質パネル検査
    • 心血管パネル検査

第7章 臨床検査薬の世界市場：エンドユーザー別

  • マーケットスナップショット
  • 臨床検査薬の世界市場：エンドユーズ別、パフォーマンス-ポテンシャル分析
  • 臨床検査薬の世界市場：エンドユース別推定・予測2019-2029
  • 臨床検査薬市場、サブセグメント別分析
    • 中央研究所
    • プライマリークリニック

第8章 臨床検査薬の世界市場：地域別分析

  • 臨床検査薬市場、地域別マーケットスナップショット
  • 北米
    • 米国
      • タイプ別の推定・予測、2019年～2029年
      • エンドユーザー別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の臨床検査薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の臨床検査薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの臨床検査薬市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第9章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Quest Diagnostics
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Abbott Laboratories
    • NeoGenomics Laboratories Inc.
    • Laboratory Corporation of America Holdings
    • ARUP Laboratories
    • OPKO Health, Inc.
    • UNILABS
    • Clinical Reference Laboratory, Inc.
    • Synnovis Group LLP
    • Sonic Healthcare Limited.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Clinical Laboratory Tests Market, report scope
  • TABLE 2. Global Clinical Laboratory Tests Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Clinical Laboratory Tests Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Clinical Laboratory Tests Market estimates & forecasts by End-Use 2019-2029 (USD Billion)
  • TABLE 5. Global Clinical Laboratory Tests Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Clinical Laboratory Tests Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Clinical Laboratory Tests Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Clinical Laboratory Tests Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Clinical Laboratory Tests Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Clinical Laboratory Tests Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Clinical Laboratory Tests Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Clinical Laboratory Tests Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Clinical Laboratory Tests Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Clinical Laboratory Tests Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Clinical Laboratory Tests Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Clinical Laboratory Tests Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Clinical Laboratory Tests Market
  • TABLE 70. List of primary sources, used in the study of global Clinical Laboratory Tests Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Clinical Laboratory Tests Market, research methodology
  • FIG 2. Global Clinical Laboratory Tests Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Clinical Laboratory Tests Market, key trends 2021
  • FIG 5. Global Clinical Laboratory Tests Market, growth prospects 2022-2029
  • FIG 6. Global Clinical Laboratory Tests Market, porters 5 force model
  • FIG 7. Global Clinical Laboratory Tests Market, pest analysis
  • FIG 8. Global Clinical Laboratory Tests Market, value chain analysis
  • FIG 9. Global Clinical Laboratory Tests Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Clinical Laboratory Tests Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Clinical Laboratory Tests Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Clinical Laboratory Tests Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Clinical Laboratory Tests Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Clinical Laboratory Tests Market, regional snapshot 2019 & 2029
  • FIG 15. North America Clinical Laboratory Tests Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Clinical Laboratory Tests Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Clinical Laboratory Tests Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Clinical Laboratory Tests Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Clinical Laboratory Tests Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Clinical Laboratory Tests Market is valued at approximately USD 94.7 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.4% over the forecast period 2022-2029. Clinical laboratory tests are medical tests that are performed on samples of blood, urine, other bodily fluids, or tissue in order to diagnose or monitor a wide range of health conditions and diseases. These tests can provide information about a person's overall health, as well as specific conditions such as infections, cancers, and genetic disorders. The market demand is primarily driven by the factors such as the global population ages, the demand for clinical laboratory tests is expected to increase, as older adults are more likely to develop age-related diseases and conditions that require diagnostic testing, coupled with Governments around the world have been investing in healthcare infrastructure and promoting healthcare access for their citizens. This has led to an increased demand for clinical laboratory tests, as more people are able to access healthcare services and are diagnosed with diseases that require laboratory testing.

In addition, the global burden of chronic diseases, such as diabetes, cardiovascular disease, and cancer, is increasing, driving demand for clinical laboratory tests to diagnose, monitor, and manage these conditions are acting as major driving factors for market growth. According to World Health Organization, Non-communicable diseases (NCDs) account for 41 million annual fatalities, or 71% of all fatalities worldwide. Between the ages of 30 and 69, more than 15 million people per year pass away from an NCD; 85% of these "premature" deaths take place in low- and middle-income nations. The majority of NCD deaths, or 17.9 million people per year, are caused by cardiovascular diseases, followed by malignancies (9.3 million), respiratory illnesses (4.1 million), and diabetes (1.5 million). Almost 80% of all NCD-related deaths that occur prematurely are caused by these four disease types, thus, in turn, these factors are expected to escalate the demand for Clinical Laboratory Tests in the global market. Furthermore, the adoption and development of data management and informatics solutions to support efficient operations, as well as recent advancements in technology are presenting lucrative opportunities for market growth over the forthcoming years. However, the ambiguous regulatory framework is restricting the market growth over the forecast period of 2022-2029.

The key regions considered for the Global Clinical Laboratory Tests Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the widespread use of several medications as well as for regional biotechnology businesses. The region market may also be driven by rising technological innovation, and as the elderly population grows, so does the demand for diagnostic tools. Whereas, Asia Pacific is also expected to grow at the highest growth rate over the forecasting period. Factors such as increasing investment in the research and development sector and the healthcare sector are burgeoning the market growth in the forecasting years.

Major market players included in this report are:

  • Quest Diagnostics
  • Abbott Laboratories
  • NeoGenomics Laboratories Inc.
  • Laboratory Corporation of America Holdings
  • ARUP Laboratories
  • OPKO Health, Inc.
  • UNILABS
  • Clinical Reference Laboratory, Inc.
  • Synnovis Group LLP
  • Sonic Healthcare Limited.

Recent Developments in the Market:

  • In March 2023, OPKO Health, Inc. stated that ModeX Therapeutics, Inc., a subsidiary of OPKO Health, had signed an exclusive licence and partnership agreement for the development of MDX-2201, ModeX's preclinical nanoparticle vaccine candidate for EBV, with Merck, also known as MSD outside of the United States and Canada.
  • In February 2023, Unilabs, a prominent diagnostic services provider, and Siemens Healthineers, a leading medical technology business, announced a multi-year agreement. Unilabs has made a significant investment in the cutting-edge technology of Siemens Healthineers and will buy more than 400 laboratory analyzers to further enhance its laboratory infrastructure and provide its clients with unmatched service.
  • In February 2023, Abbott Laboratories and Cardiovascular Systems, Inc. (CSI) signed a definitive agreement for Abbott to purchase CSI, a medical device business with a novel atherectomy system utilised in the treatment of peripheral and coronary artery disease. With the acquisition of CSI, Abbott's market-leading vascular device lineup will now include new, complementary technologies.
  • In November 2022, NeoGenomics, Inc. (NASDAQ:NEO), a company that provides of oncology testing and global contract research services, announced the launch of a novel biomarker testing programme for patients with epithelial ovarian cancer, including primary peritoneal or fallopian tube tumours (EOC). EOC patients will have access to the FOLR1 IHC CDx test (VENTANA FOLR1 RxDx Assay), carried out by NeoGenomics to assess the expression of a protein known as folate receptor alpha (FR), under the FR-ASSISTTM initiative, sponsored by ImmunoGen, Inc.

Global Clinical Laboratory Tests Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, End-Use, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Complete Blood Count
  • HGB/ HCT testing
  • Basic Metabolic Panel Testing
  • BUN Creatinine Testing
  • Electrolytes Testing
  • HbA1c Testing
  • Comprehensive Metabolic Panel Testing
  • Liver Panel Testing
  • Renal Panel Testing
  • Lipid Panel Testing
  • Cardiovascular Panel Tests

By End-Use:

  • Central Laboratories
  • Primary Clinics

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • ROLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Clinical Laboratory Tests Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Clinical Laboratory Tests Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Clinical Laboratory Tests Market, by End-Use, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Clinical Laboratory Tests Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Clinical Laboratory Tests Market Dynamics

  • 3.1. Clinical Laboratory Tests Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing geriatric population.
      • 3.1.1.2. Government initiatives to promote healthcare.
      • 3.1.1.3. Increasing prevalence of chronic and infectious diseases.
    • 3.1.2. Market Challenges
      • 3.1.2.1. Ambiguous regulatory framework.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Development of data management and informatics solutions.
      • 3.1.3.2. Recent advancements in technology.

Chapter 4. Global Clinical Laboratory Tests Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Clinical Laboratory Tests Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Clinical Laboratory Tests Market by Type, Performance - Potential Analysis
  • 6.3. Global Clinical Laboratory Tests Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Clinical Laboratory Tests Market, Sub Segment Analysis
    • 6.4.1. Complete Blood Count
    • 6.4.2. HGB/ HCT testing
    • 6.4.3. Basic Metabolic Panel Testing
    • 6.4.4. BUN Creatinine Testing
    • 6.4.5. Electrolytes Testing
    • 6.4.6. HbA1c Testing
    • 6.4.7. Comprehensive Metabolic Panel Testing
    • 6.4.8. Liver Panel Testing
    • 6.4.9. Renal Panel Testing
    • 6.4.10. Lipid Panel Testing
    • 6.4.11. Cardiovascular Panel Tests

Chapter 7. Global Clinical Laboratory Tests Market, by End-Use

  • 7.1. Market Snapshot
  • 7.2. Global Clinical Laboratory Tests Market by End-Use, Performance - Potential Analysis
  • 7.3. Global Clinical Laboratory Tests Market Estimates & Forecasts by End-Use 2019-2029 (USD Billion)
  • 7.4. Clinical Laboratory Tests Market, Sub Segment Analysis
    • 7.4.1. Central Laboratories
    • 7.4.2. Primary Clinics

Chapter 8. Global Clinical Laboratory Tests Market, Regional Analysis

  • 8.1. Clinical Laboratory Tests Market, Regional Market Snapshot
  • 8.2. North America Clinical Laboratory Tests Market
    • 8.2.1. U.S. Clinical Laboratory Tests Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End-Use breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Clinical Laboratory Tests Market
  • 8.3. Europe Clinical Laboratory Tests Market Snapshot
    • 8.3.1. U.K. Clinical Laboratory Tests Market
    • 8.3.2. Germany Clinical Laboratory Tests Market
    • 8.3.3. France Clinical Laboratory Tests Market
    • 8.3.4. Spain Clinical Laboratory Tests Market
    • 8.3.5. Italy Clinical Laboratory Tests Market
    • 8.3.6. Rest of Europe Clinical Laboratory Tests Market
  • 8.4. Asia-Pacific Clinical Laboratory Tests Market Snapshot
    • 8.4.1. China Clinical Laboratory Tests Market
    • 8.4.2. India Clinical Laboratory Tests Market
    • 8.4.3. Japan Clinical Laboratory Tests Market
    • 8.4.4. Australia Clinical Laboratory Tests Market
    • 8.4.5. South Korea Clinical Laboratory Tests Market
    • 8.4.6. Rest of Asia Pacific Clinical Laboratory Tests Market
  • 8.5. Latin America Clinical Laboratory Tests Market Snapshot
    • 8.5.1. Brazil Clinical Laboratory Tests Market
    • 8.5.2. Mexico Clinical Laboratory Tests Market
    • 8.5.3. Rest of Latin America Clinical Laboratory Tests Market
  • 8.6. Rest of The World Clinical Laboratory Tests Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Quest Diagnostics
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Abbott Laboratories
    • 9.2.3. NeoGenomics Laboratories Inc.
    • 9.2.4. Laboratory Corporation of America Holdings
    • 9.2.5. ARUP Laboratories
    • 9.2.6. OPKO Health, Inc.
    • 9.2.7. UNILABS
    • 9.2.8. Clinical Reference Laboratory, Inc.
    • 9.2.9. Synnovis Group LLP
    • 9.2.10. Sonic Healthcare Limited.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption